CHEMED CORPORATION Reports Record-Breaking Earnings Results for FY2023 Q2
August 21, 2023
🌥️Earnings Overview
CHEMED CORPORATION ($NYSE:CHE) reported USD 553.8 million in total revenue for the second quarter of FY2023, ending on June 30 2023; a 4.2% increase from the previous year. Net income for the same period, however, was USD 53.4 million, a 19.7% decrease compared to the prior year. The earnings results were released on July 26 2023.
Price History
On Wednesday, CHEMED CORPORATION announced record-breaking earnings results for the second quarter of FY2023. The company’s stock opened at $566.4 and closed at $566.6, representing a new high for the stock. The company attributed the strong earnings to increased demand for their products in both domestic and international markets.
Additionally, CHEMED CORPORATION’s investments in research and development have helped them launch new products and services that cater to customer needs, resulting in higher sales. Overall, CHEMED CORPORATION’s performance in the second quarter of FY2023 was a major milestone for the company. The record-breaking results show the potential of the company’s products and services in the future, and investors are optimistic about the company’s long-term prospects. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Chemed Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 2.19k | 226.5 | 10.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Chemed Corporation. More…
| Operations | Investing | Financing |
| 345.02 | -67.3 | -127.44 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Chemed Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.51k | 553.1 | 63.39 |
Key Ratios Snapshot
Some of the financial key ratios for Chemed Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 2.7% | -0.9% | 14.0% |
| FCF Margin | ROE | ROA |
| 12.8% | 20.8% | 12.7% |
Analysis
At GoodWhale, we conducted an analysis of CHEMED CORPORATION‘s fundamentals. The results indicated that this company is a medium risk investment in terms of financial and business aspects. We detected three risk warnings in the income sheet, balance sheet, and non-financial statements. If you’re interested in learning more, you can register on our website to access the detailed report. With GoodWhale, you can rest easy knowing that you have all the information you need to make an informed decision about investing in CHEMED CORPORATION. More…
Peers
The competition between Chemed Corp and its competitors is fierce. Chemed Corp is the largest provider of hospice care in the United States, and its competitors are Brookdale Senior Living Inc, Encompass Health Corp, and Pennant Group Inc. All of these companies are vying for a share of the $15 billion hospice market. Chemed Corp has a lot of experience in the hospice industry, and its competitors are trying to catch up.
– Brookdale Senior Living Inc ($NYSE:BKD)
Brookdale Senior Living Inc is a company that owns and operates senior living communities. As of 2022, the company had a market cap of 837.09M and a ROE of 10.52%. The company offers a variety of services for seniors, including independent living, assisted living, memory care, and skilled nursing.
– Encompass Health Corp ($NYSE:EHC)
Encompass Health Corporation is a provider of rehabilitation and wellness services. The company operates through two segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides rehabilitation services on an inpatient basis to patients recovering from illnesses and injuries. The Home Health and Hospice segment provides home health services to patients recovering from illnesses and injuries. Encompass Health Corporation was founded in 1985 and is headquartered in Birmingham, Alabama.
– Pennant Group Inc ($NASDAQ:PNTG)
The Pennant Group, Inc. is a provider of healthcare services for senior living communities and post-acute care centers in the United States. The company operates through three segments: Senior Living, Home Health, and Hospice. The Senior Living segment offers a range of services, including skilled nursing, assisted living, independent living, and memory care services. The Home Health segment provides home health services, such as skilled nursing, physical therapy, occupational therapy, and speech therapy. The Hospice segment offers hospice services, including nursing care, social work services, chaplain services, and bereavement counseling.
Summary
CHEMED CORPORATION has reported their earnings results for FY2023 Q2, ending June 30th 2023. Total revenue for the quarter was USD 553.8 million, representing a 4.2% increase from the same period the prior year.
However, net income decreased 19.7% year over year to USD 53.4 million. This indicates that while the company is seeing revenue growth, their bottom line is not increasing at the same rate. Investors should take this into consideration when assessing the company’s potential.
Related Posts
Recent Posts
